Jeffrey Cummings, M.D.


Work Titles
UCLA Professor, Neurology
Education:
Degrees:
M.D., University of Washington School of Medicine, 1974
Fellowship:
1980 - 1980 National Hospital
Internship:
1974 - 1975 Hartford Hospital
Residency:
1978 - 1979 Dept. of Veterans Affairs Medical Center, Boston
1975 - 1978 Boston Medical Center
Certifications:
Certifications:
1979 American Board of Psychiatry and Neurology

Contact Information:

Work Email Address:

jcummings@mednet.ucla.edu


Website:

Web-Profile

Work Phone Number:

(310)794-3665

Work Address:

Mary S. Eason Center for Alzheimer's Disease Research at UCLA
10911 Weyburn Ave., Suite 200
Los Angeles, CA 90095


Publications:

A selected list of publications:

Ringman JM, Younkin SG, Pratico D, Seltzer W, Cole GM, Geschwind DH, Rodriguez-Agudelo Y, Schaffer B, Fein J, Sokolow S, Rosario ER, Gylys KH, Varpetian A, Medina LD, Cummings JL   Biochemical markers in persons with preclinical familial Alzheimer disease, Neurology. 2008;71:85-92, 2008; .
Apostolova LG, Cummings JL   Neuropsychiatric manifestations in mild cognitive impairment: a systematic review of the literature. Dement Geriatr Cogn Disord, 2008;25:115-126, 2008; .
Salzman Carl, Jeste Dilip V, Meyer Roger E, Cohen-Mansfield Jiska, Cummings Jeffrey, Grossberg George T, Jarvik Lissy, Kraemer Helena C, Lebowitz Barry D, Maslow Katie, Pollock Bruce G, Raskind Murray, Schultz Susan K, Wang Philip, Zito Julie M, Zubenko George S   Elderly patients with dementia-related symptoms of severe agitation and aggression: consensus statement on treatment options, clinical trials methodology, and policy The Journal of clinical psychiatry, 2008; 69(6): 889-98.
Salloway Stephen, Mintzer Jacobo, Weiner Myron F, Cummings Jeffrey L   Disease-modifying therapies in Alzheimer's disease Alzheimer's & dementia : the journal of the Alzheimer's Association, 2008; 4(2): 65-79.
Cummings Jeffrey L, Mackell Joan, Kaufer Daniel   Behavioral effects of current Alzheimer's disease treatments: a descriptive review Alzheimer's & dementia : the journal of the Alzheimer's Association, 2008; 4(1): 49-60.
Cummings Jeffrey L   Optimizing phase II of drug development for disease-modifying compounds Alzheimer's & dementia : the journal of the Alzheimer's Association, 2008; 4(1 Suppl 1): S15-20.

Does this profile need updating? Contact Us